New York S01282 mandates full coverage for annual ovarian cancer testing in health insurance policies and requires certain health care providers to.
New York S01282 amends the insurance law to require health insurance policies to offer full coverage for annual testing for individuals at high-risk of developing ovarian cancer. This includes FDA-approved testing, transvaginal ultrasound, pelvic exams, and other exams. The coverage is exempt from annual deductibles and coinsurance. The bill also mandates that certain health care providers, such as those in primary care, offer annual ovarian cancer testing to patients at high-risk.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.